EUVIMEDEUVIMED entdecken
Crossref

Single-session EUS-directed Transgastric ERCP with a Dedicated Over-the-scope Fixation Device: A Feasibility Study

M. Bronswijk, S. Van der Merwe

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S42

DOI: 10.1055/s-0044-1782775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. Bronswijk und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

EUS-directed Transgastric ERCP (EDGE) has been proposed as a more effective alternative to enteroscopy-assisted ERCP for patients with Roux-en-Y gastric bypass anatomy, overcoming the invasiveness of laparoscopy-assisted ERCP. Postponing through-the-LAMS ERCP for 1-2 weeks and employing stent fixation techniques have been suggested to reduce the risk of stent migration. Our aim is to investigate the feasibility of a single-session EDGE using a dedicated over-the-scope fixation device.

Methods

A tertiary single-center retrospective analysis of prospectively collected data was conducted on all consecutive single-session EDGE procedures performed with the dedicated Stentfix device (Ovesco Endoscopy AG, Tuebingen, Germany). Only 20x10mm LAMS were utilized, and all cases between September 2022 and October 2023 were included. The primary outcome was LAMS migration, while key secondary outcomes included adverse events (of any kind) and technical success, defined as the successful achievement of through-the-LAMS ampullary access during a single session using a duodenoscope. Adverse events were graded using the AGREE classification.

Results

Eleven patients were identified, with a mean age of 56 years (SD±11.7), and a female predominance of 63.6%. All patients had classic Roux-en-Y gastric bypass anatomy and underwent ERCP for various reasons: bile duct stones (n=7, 63.6%), cholangitis (n=2, 18.2%), and post-cholecystectomy leaks (n=2, 18.2%). No LAMS migrations occurred, and technical success was achieved in 10 out of 11 patients (90.9%). After a median follow-up time of 97 days (IQR 29-231), one adverse event (grade I) was reported, involving postprocedural pain which resolved following administration of mild opioid analgesia and subsequent removal of the stent. The median procedure time was 45 minutes (IQR 41-51). The median LAMS dwell time was 29 days (IQR 21-53), and the majority of fistulae (75%) were closed immediately after LAMS removal, using an over-the-scope clip. The median body mass change during LAMS implantation was+2kg (IQR 0-2).

Conclusions

While acknowledging that factors such as the endoscopist’s experience, LAMS orientation, and a larger stent size (20mm vs 15mm) cannot be definitively excluded as contributing elements, our data strongly suggest that the utilization of a dedicated over-the-scope stent fixation device prevents LAMS migration during the same-session EDGE Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Bronswijk, M., & Merwe, S. V. D. (2024). Single-session EUS-directed Transgastric ERCP with a Dedicated Over-the-scope Fixation Device: A Feasibility Study. Endoscopy, 56(S 02 S 02), S42. https://doi.org/10.1055/s-0044-1782775

Vancouver

Bronswijk M, Merwe SVD. Single-session EUS-directed Transgastric ERCP with a Dedicated Over-the-scope Fixation Device: A Feasibility Study. Endoscopy. 2024;56(S 02 S 02):S42. doi:10.1055/s-0044-1782775

BibTeX
@article{Bronswijk2024,
  author = {Bronswijk, M. and Merwe, S. Van der},
  title = {Single-session EUS-directed Transgastric ERCP with a Dedicated Over-the-scope Fixation Device: A Feasibility Study},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S42},
  doi = {10.1055/s-0044-1782775}
}
Kostenlos starten →